Cardiovascular Disease in Patients with Diabetes: A Comparison of Professional Society Guidelines

被引：2
作者：
Salazar, Ilton M. Cubero [1 ,2 ]
Tibuakuu, Martin [1 ,2 ]
Blumenthal, Roger S. [1 ,2 ]
Sarkar, Sudipa [1 ,3 ]
机构：
[1] Johns Hopkins Univ Hosp, Johns Hopkins Ciccarone Ctr Prevent Cardiovasc Di, Baltimore, MD 21287 USA
[2] Johns Hopkins Univ Hosp, Dept Med, Div Cardiol, Baltimore, MD 21287 USA
[3] Johns Hopkins Univ Hosp, Dept Med, Div Endocrinol Diabet & Metab, Baltimore, MD 21287 USA
来源：
CURRENT DIABETES REVIEWS | 2022年 / 18卷 / 04期
关键词：
Diabetes; cardiovascular disease; hypertension; atherosclerosis; hyperlipidemia; AMERICAN-COLLEGE; STATIN THERAPY; RISK; OUTCOMES; ASSOCIATION; EZETIMIBE; EFFICACY; DESIGN; SAFETY;
D O I：
10.2174/1573399817666210820105514
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In this review, we compare major points given in the 2021 American Diabetes Association and the 2020 American Association of Clinical Endocrinologists/American College of Endocrinology guidelines, in particular, the assessment and management of cardiovascular risk in patients with diabetes with a focus on dyslipidemia, blood pressure, and pharmacotherapy in diabetes.
引用
收藏
页数：7
相关论文
共 50 条
  • [21] Brazilian guidelines on prevention of cardiovascular disease in patients with diabetes: a position statement from the Brazilian Diabetes Society (SBD), the Brazilian Cardiology Society (SBC) and the Brazilian Endocrinology and Metabolism Society (SBEM)
    Bertoluci, Marcello Casaccia
    Moreira, Rodrigo Oliveira
    Faludi, Andre
    Izar, Maria Cristina
    Schaan, Beatriz D.
    Valerio, Cynthia Melissa
    Bertolami, Marcelo Chiara
    Chacra, Ana Paula
    Bolivar Malachias, Marcus Vinicius
    Vencio, Sergio
    Kerr Saraiva, Jose Francisco
    Betti, Roberto
    Turatti, Luiz
    Helfenstein Fonseca, Francisco Antonio
    Bianco, Henrique Tria
    Sulzbach, Marta
    Bertolami, Adriana
    Nunes Salles, Joao Eduardo
    Hohl, Alexandre
    Trujilho, Fabio
    Lima, Eduardo Gomes
    Miname, Marcio Hiroshi
    Zanella, Maria Teresa
    Lamounier, Rodrigo
    Sa, Joao Roberto
    Amodeo, Celso
    Pires, Antonio Carlos
    Santos, Raul D.
    DIABETOLOGY & METABOLIC SYNDROME, 2017, 9
  • [22] Cardiovascular events, diabetes and guidelines: the virtue of simplicity
    Esper, Ricardo J.
    Nordaby, Roberto A.
    CARDIOVASCULAR DIABETOLOGY, 2019, 18 (1)
  • [23] Brazilian guidelines on prevention of cardiovascular disease in patients with diabetes: a position statement from the Brazilian Diabetes Society (SBD), the Brazilian Cardiology Society (SBC) and the Brazilian Endocrinology and Metabolism Society (SBEM)
    Marcello Casaccia Bertoluci
    Rodrigo Oliveira Moreira
    André Faludi
    Maria Cristina Izar
    Beatriz D. Schaan
    Cynthia Melissa Valerio
    Marcelo Chiara Bertolami
    Ana Paula Chacra
    Marcus Vinicius Bolivar Malachias
    Sérgio Vencio
    José Francisco Kerr Saraiva
    Roberto Betti
    Luiz Turatti
    Francisco Antonio Helfenstein Fonseca
    Henrique Tria Bianco
    Marta Sulzbach
    Adriana Bertolami
    João Eduardo Nunes Salles
    Alexandre Hohl
    Fábio Trujilho
    Eduardo Gomes Lima
    Marcio Hiroshi Miname
    Maria Teresa Zanella
    Rodrigo Lamounier
    João Roberto Sá
    Celso Amodeo
    Antonio Carlos Pires
    Raul D. Santos
    Diabetology & Metabolic Syndrome, 9
  • [24] Incidence of depression in patients with cardiovascular disease and type 2 diabetes: a nationwide cohort study
    Zareini, Bochra
    Sorensen, Katrine Kold
    Blanche, Paul
    Falkentoft, Alexander C.
    Fosbol, Emil
    Kober, Lars
    Torp-Pedersen, Christian
    CLINICAL RESEARCH IN CARDIOLOGY, 2024, 113 (11) : 1523 - 1533
  • [25] Progression of cardiovascular autonomic neuropathy and cardiovascular disease in type 2 diabetes
    Yun, Jae-Seung
    Park, Yong-Moon
    Cha, Seon-Ah
    Ahn, Yu-Bae
    Ko, Seung-Hyun
    CARDIOVASCULAR DIABETOLOGY, 2018, 17
  • [26] Diabetes, Cardiovascular Disease, and Cardiovascular Risk in Patients with Chronic Kidney Disease
    De Lima, Jose J. G.
    Gowdak, Luis Henrique W.
    David-Neto, Elias
    Bortolotto, Luiz A.
    HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION, 2021, 28 (02) : 159 - 165
  • [27] Personalizing Glucose-Lowering Therapy in Patients with Type 2 Diabetes and Cardiovascular Disease
    Inzucchi, Silvio E.
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2018, 47 (01) : 137 - +
  • [28] Diabetes, Cardiovascular Disease, and Cardiovascular Risk in Patients with Chronic Kidney Disease
    Jose J. G. De Lima
    Luis Henrique W. Gowdak
    Elias David-Neto
    Luiz A. Bortolotto
    High Blood Pressure & Cardiovascular Prevention, 2021, 28 : 159 - 165
  • [29] Genotyping and phenotyping of Haptoglobin gene polymorphisms and their correlation with cardiovascular disease and biochemical parameters in Iranian patients with type 2 diabetes mellitus
    Khodarahmi, Ameneh
    Ghanbarzadeh, Fatemeh
    Hemati, Mahdie
    Bishomar, Elaheh
    Salehi-Abargouei, Amin
    Moradi, Ali
    HUMAN GENE, 2024, 40
  • [30] An estimation of the consequences of reinforcing the 2016 and 2019 European Society of Cardiology/European Atherosclerosis Society guidelines on current lipid-lowering treatment in patients with type 2 diabetes in tertiary care-a SwissDiab study
    Singeisen, Helene
    Renstrom, Frida
    Laimer, Markus
    Lehmann, Roger
    Bilz, Stefan
    Brandle, Michael
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2023, 30 (14) : 1473 - 1481
12345